Key PBS listing to save Australians with severe back and neck pain more than $20,000
Thousands of Australians with debilitating back and joint pain will have access to a life changing treatment option through the Pharmaceutical Benefits Scheme (PBS) which would otherwise cost tens of thousands of dollars. From December 1, access to Taltz® (ixekizumab) on the PBS will be expanded for patients with active ankylosing spondylitis. Without the PBS…